Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines. (Q40599916)
Jump to navigation
Jump to search
scientific article published on July 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines. |
scientific article published on July 2001 |
Statements
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines (English)
Pfreundschuh M
Hartmann F
Renner C
Jung W
da Costa L
Tembrink S
Held G
Sek A
Bauer S